Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
acute, adenosine, administered, alisertib, aurora, broader, civil, clear, comply, conclusion, crystalline, decision, distract, domestic, education, Fabre, ground, head, lengthy, leukemia, lifted, lose, lymphoma, Markman, Millennium, mix, move, myeloid, neck, newly, ovarian, Overnight, percent, peripheral, pharmacological, Pierre, progressed, proliferating, rapidly, show, small, SOFR, sponsorship, Takeda, tiered, training, unpredictable
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view